Spironolactone

Product NDC
68071-2606
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
spironolactone
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
NuCare Pharmaceuticals,Inc.
Application
ANDA203512
Marketing category
ANDA
Substance
SPIRONOLACTONE
Current FDA listing
Historical FDA.report record

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
68071-2606-330 TABLET, FILM COATED in 1 BOTTLE (68071-2606-3) 2021-12-230000-00-00NoCurrent
68071-2606-990 TABLET, FILM COATED in 1 BOTTLE (68071-2606-9) 2021-12-230000-00-00NoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SpironolactoneNuCare Pharmaceuticals,Inc.2023-07-14HUMAN PRESCRIPTION DRUG LABEL3